A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer

BACKGROUND: The response to neoadjuvant chemotherapy has been proven to predict long-term clinical benefits for patients. Our research is to construct a nomogram to predict pathological complete response of human epidermal growth factor receptor 2 negative breast cancer patients. METHODS: We enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xi, Jiang, Yi-Zhou, Chen, Sheng, Yu, Ke-Da, Ma, Ding, Sun, Wei, Shao, Zhi-Min, Di, Gen-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974800/
https://www.ncbi.nlm.nih.gov/pubmed/27495967
http://dx.doi.org/10.1186/s12885-016-2652-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974800/
https://www.ncbi.nlm.nih.gov/pubmed/27495967
http://dx.doi.org/10.1186/s12885-016-2652-z

Ejemplares similares